Gb002, Inc., A Wholly Owned Subsidiary Of Gossamer Bio, Inc.

This study continues monitoring patients with pulmonary arterial hypertension who previously took the inhaled medication GB002. Researchers want to understand the long-term safety and whether the drug continues to help patients walk farther. The study includes 74 people who compl…